MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01873nam a2200313Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
MX-MdCICY |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20250625153851.0 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
CICY |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
B-12352 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
250602s9999 xx |||||s2 |||| ||und|d |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer |
| 490 0# - SERIES STATEMENT |
|---|
| Volume/sequential designation |
BioChemical Pharmacology, 80(12), p.1833-1843, 2010 |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Extensive research within the last two decades has revealed that most chronic illnesses, including cancer, diabetes, and cardiovascular and pulmonary diseases, are mediated through chronic inflammation. Thus, suppressing chronic inflammation has the potential to delay, prevent, and even treat various chronic diseases, including cancer. Various nutraceuticals from fruits, vegetables, vitamins, spices, legumes, and traditional Chinese and Ayurvedic medicine have been shown to safely suppress proinflammatory pathways; however, their low bioavailability in vivo limits their use in preventing and treating cancer. We describe here the potential of nanotechnology to fill this gap. Several nutraceuticals, including curcumin, green tea polyphenols, coenzyme Q, quercetin, thymoquinone and others, have been packaged as nanoparticles and proven to be useful in ''nanochemoprevention'' and ''nanochemotherapy''. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
INFLAMMATION |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
DIABETES |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
CANCER |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
NF-KB |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
CURCUMIN |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
NUTRACEUTICALS |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
NANOTECHNOLOGY |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nair, H.B. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Sung, B. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Yadav, B.R. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Kannappan, R. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Chaturvedi, M.M. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Aggarwal, B.B. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://drive.google.com/file/d/1VgZSKySr5qSBSIlMdntKJuwycRPNeL_1/view?usp=drivesdk">https://drive.google.com/file/d/1VgZSKySr5qSBSIlMdntKJuwycRPNeL_1/view?usp=drivesdk</a> |
| Public note |
Para ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Clasificación local |
| Koha item type |
Documentos solicitados |
